Coloplast A/S (CLPBY)

Market Cap	16.73B -24.0%
Revenue (ttm)	4.35B +2.1%
Net Income	422.22M -32.2%
EPS	1.87 -32.2%
Shares Out	n/a
PE Ratio	39.63
Forward PE	18.53
Dividend	0.22 (2.98%)
Ex-Dividend Date	May 22, 2026

Volume	29,669
Open	7.37
Previous Close	7.40
Day's Range	7.26 - 7.41
52-Week Range	5.64 - 10.03
Beta	0.55
Analysts	Hold
Price Target	8.32 (+14.6%)
Earnings Date	Aug 18, 2026

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 17,213
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLPBY

Financial Performance

In fiscal year 2025, Coloplast's revenue was 27.87 billion, an increase of 3.12% compared to the previous year's 27.03 billion. Earnings were 3.64 billion, a decrease of -28.03%.

Financial numbers in DKK

Analyst Summary

According to 4 analysts, the average rating for CLPBY stock is "Hold." The 12-month stock price target is $8.32, which is an increase of 14.60% from the latest price.

Price Target

$8.32

(14.60% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 3, 2026

Data Sources Report a data error